D-0248-2025 Class II Terminated
FDA drug recall D-0248-2025 was initiated by Turbare Manufacturing on Feb 18, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: due to a quality control process deviation The recall status is terminated (terminated Feb 26, 2026). Affected quantity: 1,147 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 5, 2025
- Initiation Date
- Feb 18, 2025
- Termination Date
- Feb 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,147 syringes
Product description
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
Reason for recall
Lack of Assurance of Sterility: due to a quality control process deviation
Distribution pattern
Nationwide in the USA
Code information
Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0248-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026